HK Stock Market Move | DIAGENS-B(02526) rose more than 7% Core business is large model medical imaging AI base

The "medical imaging big model first stock" DIAGENS-B (02526) surged more than 7% this morning, rising by 6.84% as of press time to HK$250 with a turnover of HK$187.841 million. It is understood that Des Technologies focuses on the underlying technological innovation in the field of AI medical imaging. Its self-developed iMedImage medical imaging platform model supports 19 types of imaging modalities, empowering over 90% of clinical imaging scenarios. Based on massive pre-training data, iMedImage can quickly train disease-specific imaging diagnostic models, achieving an industry breakthrough of "few samples, low computing power, fast training." In addition, the company's core product AI AutoVision has been recognized by the National Medical Products Administration as a Class III Innovative Medical Management Device, and is expected to become the first intelligent chromosome karyotype assistant diagnostic software approved for market in China. In the first 9 months of 2025, the company achieved a year-on-year revenue surge of 469.8% to reach 112 million yuan, with a gross profit margin as high as 75.9%. The gross profit margin of the technology licensing business even reached 96.5%.